PJT Partners Inc.
PJT Partners Inc. Q2 FY2025 earnings call
July 29, 2025 · fiscal period ended 2025-06
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-07-29
Management highlights
Management Statement and Operational Highlights:
- Paul began by mourning the loss of life in Midtown Manhattan and then discussed earnings results: Q2 revenues $407M (+13%), adjusted pretax income $80M (+22%), adjusted EPS $1.54 (+29%); H1 revenues +6%, adjusted pretax income +13%, adjusted EPS +19%.
- Market backdrop improved with equity valuations up, volatility down, and capital more available.
- Helen discussed financial results: adjusted comp expense ratio 67.5% for H1 2025, adjusted noncomp expense up, adjusted pretax margin improved, share repurchases, balance sheet strength, and approved quarterly dividend of $0.25 per share.
- Paul detailed segment performance: restructuring's market leadership, PJT Park Hill's fundraising challenges and H2 outlook, Strategic Advisory's record performance and pipeline with 4 new partners joining.
Segment performance
Segment Performance:
- Strategic Advisory: Delivered record performance in Q2 and first half, driven by increased transaction closings and fee realizations. Year-to-date M&A activity mixed, but preannounced strategic advisory pipeline is at record levels.
- Restructuring: Experiencing elevated liability management activity, ranked #1 in U.S. and global restructurings for H1 2025, with H1 revenues bettering last year's record. Full-year results expected to at least match last year's record levels.
- PJT Park Hill: Primary fundraising environment challenged due to low capital return and increased first-time fund launches, resulting in lower revenues in Q2 and H1. However, expects stronger performance in H2 due to strong pipeline in primary and private capital solutions.
Guidance
Guidance:
- Strategic advisory expected to be up strongly from 2024's record levels.
- Restructuring and PJT Park Hill expected to deliver results in line with last year's record levels.
- Continuation funds are here to stay with room to grow, substituting for some regular way IPOs.
Risks
Risks:
- Forward-looking statements subject to various risks and uncertainties where actual outcomes could differ materially from statements. Factors described in PJT Partners' 2024 Form 10-K.
Q&A highlights
Question and Answer: Q: James Yaro asked about sponsor M&A and when sponsor sell sides might start to come back.
A: Paul said sponsor activity is increasing with IPO market more receptive, credit markets more accommodative, and strategic interest returning, though still slow to normalize.
Q: Jim Mitchell asked about leveraging Park Hill franchise for middle market deals.
A: Paul said they're in early days but having holistic conversations with fund managers, still early to fully mine the opportunity.
Q: Brendan O'Brien asked about regulatory front and M&A trajectory.
A: Paul said better than prior administration, but still complicated in some industries, with M&A recovery gradual but improving.
Q: Alex Bond asked about Park Hill fundraising and scaling.
A: Paul said fundraising has lumpiness, more in back half, secondary business better due to supply-demand match, and flight to quality benefits PJT Park Hill.
Q: Devin Ryan asked about network effects and investments.
A: Paul said network effects seen daily, still early days, with opportunities in Japan, Europe, Gulf, etc., and optimism for scaling restructuring outside U.S.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $1.54 | $1.36 | +13.2% | — |
| Revenue | $406.9M | $409.6M | -0.7% | — |
Transcript
July 29, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.